2m 2m 2m 2m 2m 2m 2m
CDT Equity (CDT)
NASDAQ
$0.51-$0.003 (-0.59%)
Price as of Nov 12, 2026 8:35 AM EST- $10.4MMarket Cap
- -100.00%1-Year Change
- BiotechnologyIndustry
CDT Equity (CDT)
$0.51-$0.003 (-0.59%)
CDT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.51 | ||
Change | -$0.05 (-9.14%) | ||
Open | $0.48 | ||
High | $0.56 | ||
Low | $0.45 | ||
Previous Close | $0.56 | ||
Volume | 1,431,628 | ||
30-Day Average Volume | 2,397,294 | ||
1-Week Change | -49.90% | ||
1-Month Change | -96.45% | ||
1-Year Change | -100.00% | ||
3-Year Change | -100.00% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 20.4M | ||
Total Assets | $126.7M | ||
Market Cap | $10.4M | ||
Enterprise Value | $9.6M | ||
Period: QTR TTM FY | |||
Revenue | $341,000.00 | ||
Net Income | -$4.7M | ||
Free Cash Flow | -$544,000.00 | ||
EBIT | -$4.7M | ||
EBITDA | -$4.6M | ||
Net Working Capital | -$20.4M | ||
EPS | -$43,550.00 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | 28 | ||
P/B | N/A | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 11/06/2026 | ||
Earnings & Revenue